1213846-75-3 Usage
Uses
Given the provided materials do not specify the uses of (R)-Cyclopropyl(2-fluorophenyl)MethanaMine hydrochloride, it is not possible to list its applications as was done for Gallotannin. However, based on the structural features of the compound, one could hypothesize potential uses in various industries such as pharmaceuticals, materials science, or as an intermediate in chemical synthesis, pending further research and context-specific information.
If future data becomes available detailing specific applications, the uses could be listed as follows:
Used in Pharmaceutical Industry:
(R)-Cyclopropyl(2-fluorophenyl)MethanaMine hydrochloride could be used as an active pharmaceutical ingredient for [specific medical purpose] due to its unique structural features that may allow it to interact with biological targets in a novel way.
Used in Materials Science:
In the field of materials science, (R)-Cyclopropyl(2-fluorophenyl)MethanaMine hydrochloride might serve as a component in the development of new materials with [specific properties], leveraging its structural attributes to enhance material performance.
Used in Chemical Synthesis:
As an intermediate in chemical synthesis, (R)-Cyclopropyl(2-fluorophenyl)MethanaMine hydrochloride could be utilized for the production of more complex molecules, taking advantage of its reactive sites and structural elements to form desired end products.
Check Digit Verification of cas no
The CAS Registry Mumber 1213846-75-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,3,8,4 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1213846-75:
(9*1)+(8*2)+(7*1)+(6*3)+(5*8)+(4*4)+(3*6)+(2*7)+(1*5)=143
143 % 10 = 3
So 1213846-75-3 is a valid CAS Registry Number.
1213846-75-3Relevant academic research and scientific papers
New quinoline NK3 receptor antagonists with CNS activity
Smith, Paul W.,Wyman, Paul A.,Lovell, Peter,Goodacre, Caroline,Serafinowska, Halina T.,Vong, Antonio,Harrington, Frank,Flynn, Sean,Bradley, Daniel M.,Porter, Rod,Coggon, Sara,Murkitt, Graham,Searle, Kirsten,Thomas, David R.,Watson, Jeannette M.,Martin, William,Wu, Zining,Dawson, Lee A.
scheme or table, p. 837 - 840 (2009/09/06)
Lead optimisation starting from the previously reported selective quinoline NK3 receptor antagonists talnetant 2 (SB-223412) and 3 (SB-222200) led to the identification of 3-aminoquinoline NK3 antagonist 10 (GSK172981) with excellent CNS penetration. Investigation of a structurally related series of sulfonamides with reduced lipophilicity led to the discovery of 20 (GSK256471). Both 10 and 20 are high affinity, potent NK3 receptor antagonists which despite having different degrees of CNS penetration produced excellent NK3 receptor occupancy in an ex vivo binding study in gerbil cortex.
